Support Our Work

Please donate so we can continue our work to reduce the stigma of psychiatric illness, encourage research, and support educational activities for behavioral health professionals and the public. Ways you can donate and help are on our Support and Donations page. Thank you!

More Info

Latest News Around the Web

New York City Mayor Announces Effort To Require Involuntary Hospitalization Of People With Mental Illness Experiencing Homelessness

The New York Times (11/29, A1, Newman, Fitzsimmons) reports New York City Mayor Eric Adams “announced a major push on Tuesday to remove people with severe, untreated mental illness from the city’s streets and subways.” Adams, “who has made clearing homeless encampments a priority since taking office in January, said the effort would require involuntarily hospitalizing people who were a danger to themselves, even if they posed no risk of harm to others, arguing the city had a ‘moral obligation’ to help them.”

Reuters (11/29, Borter) reports, “Adams said the city would immediately provide training for emergency personnel, hospital staff and other outreach workers on how to provide ‘compassionate care’ while removing someone from the streets who is undergoing a mental health crisis.”

Related Links:

— “New York City to Involuntarily Remove Mentally Ill People From Streets ” Andy Newman and Emma G. Fitzsimmons, The New York Times, November 29, 2022

Strong Placebo Response May Contribute Significantly To Perception Of Pain Reduction Observed In Clinical Trials Of Cannabis-Based Therapies, Systematic Review Suggests

Psychiatric News (11/28) reports, “A strong placebo response contributes significantly to the perception of pain reduction observed in clinical trials of cannabis-based therapies, according to” the findings of a 20-study, 1,459-adult patient systematic review and meta-analysis published online Nov. 28 in JAMA Network Open. Additionally, the research “suggests that media coverage of cannabis trials may promote high expectations of pain relief in clinical trial participants, thus increasing the placebo effect.”

Related Links:

— “Media Coverage, Placebo Response Linked to Pain Relief Seen in Cannabinoid Trials, Psychiatric News, November 28, 2022

Schizophrenia One Of The Most Stigmatized Mental Illnesses

USA Today (11/28, Ryu) reports, “Schizophrenia is a lifelong, psychotic disorder that affects fewer than 1% of the U.S. population, but is one of the most stigmatized mental illnesses,” affecting “how people think, feel and act.” While “people have also associated it with mass violence or shootings,” mental health clinicians “warn the relationship between schizophrenia and violence is often oversimplified and rarely ever causal.” Even though “it’s true that some may exhibit aggression or unpredictability when their symptoms go untreated or when combined with substance use, research has supported that most are not actually violent.” In fact, “serial killers are more likely to exhibit antisocial personality disorders (such as sociopathy or psychopathy), according to the American Psychiatric Association, and those with schizophrenia are at increased risk of becoming victims, rather than perpetrators, of violence.”

Related Links:

— “Do you really know what schizophrenia is? Most people don’t. “Jenna Ryu, USA Today, November 28, 2022

Poll Suggests 45% Of Americans Are Worried About Their Mental Health During Upcoming Holiday Season

Healio (11/28) reports, “According to a recently released survey, 45% of Americans are worried about their mental health” during the upcoming holiday season. The “results of the poll, from BetterHelp, were made in conjunction with global research company Material, from an online survey of 1,009 American adults in November.” Findings from the poll “revealed that 72% of Americans expect something to negatively impact their mental wellbeing this winter, with the economy and managing family dynamics topping the list.”

Related Links:

— “Poll: 45% of Americans concerned about mental health during holidays “Shenaz Bagha, Healio, November 28, 2022

Nonaffective psychotic disorders a risk factor for all-cause dementia

Neurology Advisor (11/23, Jacobs) reported, “Nonaffective psychotic disorders are an important, potentially modifiable risk factor for all-cause dementia, with individuals with these disorders warranting close monitoring for cognitive decline in later life,” investigators concluded in the findings of a 13-study systematic review and meta-analysis published in the journal Psychological Medicine.

Related Links:

— “Psychotic Disorders as a Potentially Modifiable Risk Factor for Dementia “Sheila Jacobs, Neurology Advisor, November 23, 2022

Foundation News

Nothing Found

It seems we can’t find what you’re looking for. Perhaps searching can help.